EU country and CE Marking

In May 2004, the European Union expanded to 25 countries representing 22 different languages.

Three additional countries (indicated with a * below), although not officially part of the European Union, comprise what is know as the European Economic Area (EEA).

Switzerland** is not an EU member nor a signatory of the EEA, but has incorporated the MDD and IVDD into their national law. All require CE marking for Medical Devices and IVD.

They include:
AUSTRIA
LIECHTENSTEIN*
BELGIUM
LITHUANIA
CYPRUS
LUXEMBOURG
CZECH REPUBLIC
MALTA
DENMARK
NORWAY*
ESTONIA
POLAND
FINLAND
PORTUGAL
FRANCE
SLOVAKIA
GERMANY
SLOVENIA
GREECE
SPAIN
HUNGARY
SWITZERLAND **
ICELAND*
SWEDEN
IRELAND
THE NETHERLANDS
ITALY
UNITED KINGDOM
LATVIA

Comments

Post a Comment

Popular posts from this blog

Once-Daily 'Male Pill' Shows Promise in Early Study

Image
CHICAGO, Illinois — An investigational oral synthetic androgen shows promise as a possible male contraceptive pill in a new month-long study.

Dose-finding and safety results of the trial in 82 healthy men were presented March 18 here ENDO 2018: The Endocrine Society Annual Meeting by Arthi Thirumalai, MBBS, acting assistant professor, University of Washington, Seattle.

"It only needs to be dosed once a day, and we didn't see any significant side effects, but it needs to be tested much longer. This is a very early phase," Study coauthor Stephanie Page, MD, PhD, professor of medicine at the university, told Medscape Medical News.

The agent, dimethandrolone undecanoate (DMAU), is a prodrug that is converted to dimethandrolone (DMA), which binds to both androgen and progesterone receptors. The long-chain fatty acid component undecanoate slows the drug's clearance, enabling the once-daily dosing.

During a press briefing, Page showed data from a multinational survey i…
Read more

Inflammatory Bowel Disease an Independent Risk Factor for MI

Image
Patients with inflammatory bowel disease (IBD) are at significantly higher risk for myocardial infarction (MI), particularly younger patients and women, compared with the general population, new research suggests.

The study emphasizes the need for closer monitoring and aggressive attention to cardiovascular risk factors, say the researchers.

"Patients with IBD who present with any cardiovascular complaints, including chest pain or shortness of breath, should be thoroughly evaluated by their physicians for a potential heart condition," lead investigators, Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Ohio, advised in an email to theheart.org | Medscape Cardiology.

"Our hope is that this study prompts clinicians who care for IBD patients to start thinking about IBD as an additional risk factor for heart disease and to also screen them and treat their risk factors aggressively,&q…
Read more

Inflamation and Alzheimer disease

Image
A new study shows that microglia, which are the immune cells of the central nervous system, can "remember" inflammation. This "memory" influences how the cells react to new stimuli and deal with toxic plaque in the brain, a marker of Alzheimer's disease.

The brain's immune cells remember previous inflammation. Microglia, sometimes referred to as "scavenger" cells, "are the primary immune cells of the central nervous system."
As the key player in the brain's immunity, microglia are dispatched to the site of infection or injury, where they fight toxic agents or pathogens and get rid of useless cells.
However, these cells are also known to play a negative role in neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, ischemic stroke, and traumatic brain injuries.
For instance, a recent study showed that when microglia are overactive, they devour toxic plaques along with synapses, which presumably leads…
Read more